Invesaro

Stocks IDT Financial statements

Financial statements

IDT CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data IDT CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue1,5021,5471,4091,3461,4471,3641,2391,2061,2311,298
Cost of revenue1,2761,3061,039882816785801
Gross profit226241325357390446497
Research and development474850.65155.7
Selling, general and administrative188203204215218217243270288318
Operating expenses1,4861,5371,4021,3231,391265296325346376
Operating income5.558.38-1.0117.95760.160.764.8100121
Other non-operating income0.82-1.350.68-1.277.92-25.4-3.08-7.61-0.712.25
Pre-tax income7.628.10.4517.765.234.960.861.9106130
Income tax-2.022.90.12-3.7-31.75.8816.4-6.3524.734.9
Net income to minority interests1.460.990.2-0.010.421.983.873.815.058.46
Net income8.184.210.1321.496.52740.564.576.186.6
EBITDA27.331.221.638.374.878.280.985.1121143
EPS, basic0.350.170.010.823.781.051.592.553.023.47
EPS, diluted0.350.170.010.813.701.031.582.543.013.46
Shares, basic (weighted)23.224.725.326.325.525.825.525.225.225
Shares, diluted (weighted)23.324.725.326.426.126.425.625.425.325
Dividend per share0.760.560.100.220.26

Balance sheet

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents90.37480.284.910798.4104165227221
Short-term investments58.35.97
Receivables6570.758.144.246.639.532.142.244.960.8
Other current assets18.728.424.719.316.823.628.425.928.730.9
Total current assets371329368322388363387423520655
Property, plant and equipment8936.134.430.130.836.938.738.738.941.9
Lease right-of-use assets9.497.677.215.543.271.881.45
Goodwill11.311.311.212.914.926.426.526.326.526.5
Intangible assets0.50.54.23.967.589.618.26.295.068.76
Long-term investments26.96.639.328.8311.77.439.876.526.666.07
Other non-current assets3.6610.511.68.9110.410.310.911.58.166.21
Total assets519400444405513497511550626764
Accounts payable4145.937.125.224.528.522.224.819.418.6
Accrued liabilities12513012812612911711110397.3106
Deferred revenue76.55542.540.142.336.535.330.427.727.1
Total current liabilities363367389325339305294279293352
Lease liabilities7.355.474.612.881.531.10.82
Other non-current liabilities1.081.311.081.391.236.593.352.661.693.61
Total liabilities364368390334346316300284296356
Paid-in capital394294273277278296301304308319
Retained earnings-163-173-161-139-42.9-15.824.786.6157237
Treasury stock-83.3-85.6-51.7-56.2-60.4-102-115-126-144-165
Other comprehensive income-2.34-4.97-4.86-7.41-10.2-11.3-17.2-18.1-16.6-14.1
Shareholders' equity14630.756.274.8165168194246305377
Minority interests8.820.64-2.69-3.631.753.026.279.4713.818.8
Total equity15531.353.671.1167171200256319396
Total liabilities and equity519400444405513497511550626764

Cash flow statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income9.645.20.3321.496.92944.468.381.195.1
Depreciation and amortization21.722.822.620.417.818.120.120.42121.4
Stock-based compensation3.743.582.243.861.491.934.527.43.0710.5
Deferred income tax2.33-6.17-1.08-3.92-334.2413.6-9.8316.20.75
Change in receivables-18-6.677.5911.70.98-8.284.73-13.7-5.99-19.2
Change in payables16.712.8-7.55-12.1-0.26-1.11-21-9.08-4.8122.7
Cash from operations36.120.485.1-29.666.629.452.478.212791.1
Capital expenditures-22.9-20.6-18.7-16-16.8-21.9-22-18.9-20.8-23.1
Acquisitions-1.83-5.53-0.45-3.67-7.5500-1.5
Purchases of investments-9.44-22.5-8.28-22.4-43.2-24.5-59.9-29.9-33.5-64.4
Sales and maturities of investments0.0241.56.316.4626.221.249.250.136.343.3
Cash from investing-39.6-1.64-26.2-32.5-44.1-33.8-33.5-0.75-20.7-47.7
Stock issued24.913.30.280.690.140.170.1700.2
Share buybacks-1.84-2.29-3.88-4.48-4.19-26.2-13.9-10.6-17.8
Dividends paid-17.9-13.9-2.54-5.55-6.5
Cash from financing6.82-26.67.22-5.65-4.52-15.6-14.1-17.2-23.4-30.6
Exchange rate effect0.29-0.96-12.211.77.66-17.44.39-3.583.48
Net change in cash3.6-8.7754-5625.7-37.49.2656.686.417.5
Free cash flow13.1-0.1766.5-45.649.97.5330.459.310668
Interest paid0.290.090.190.390.490.460.540.430.110.18
Income taxes paid0.580.190.050.060.190.110.780.530.2822.2

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $83.22 on November 10, 2026.

Profitability

MetricValueHow it is calculated
Gross margin38.3%Gross profit / revenue.
Operating margin9.3%Operating income / revenue.
EBITDA margin11.0%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin10.0%Pre-tax income / revenue.
Net margin6.7%Net income / revenue.
FCF margin5.2%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin7.0%Cash from operations / revenue.
Effective tax rate26.8%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)25.4%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)12.5%Net income / average total assets.
Return on invested capital (ROIC)75.4%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue4.3%Research and development expense / revenue.
SG&A / revenue24.5%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.8%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue1.8%Capital expenditures / revenue.
D&A / revenue1.6%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y5.4%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y1.6%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y-2.2%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y11.3%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y11.6%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income growth, 1y20.7%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y25.9%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y16.3%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y17.4%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y20.8%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y13.8%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y13.9%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y28.9%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y-2.1%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y15.0%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y29.9%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y-1.3%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-28.3%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y20.2%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y6.5%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-36.1%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y30.7%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y6.4%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y18.2%Dividend per share vs the same period a year earlier. Only from a positive base.
Book value growth, 1y23.7%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y24.9%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y18.0%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y22.0%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y14.4%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y8.3%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-1.1%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-0.7%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-0.8%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.86xCurrent assets / current liabilities.
Quick ratio0.80x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.63x(Cash + short-term investments) / current liabilities.
Liabilities / assets46.6%Total liabilities / total assets.
Working capital$303.5MCurrent assets - current liabilities.
Goodwill and intangibles / assets4.6%(Goodwill + intangible assets) / total assets.
Tangible book value$342.0MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.87xRevenue / average total assets.
Fixed asset turnover32.2xRevenue / average property, plant and equipment.
Receivables turnover24.6xRevenue / average receivables.
Days sales outstanding15 days365 x average receivables / revenue.
Days payables9 days365 x average accounts payable / cost of revenue.
FCF conversion78.4%Free cash flow / net income, when net income is positive.
Capex / operating cash flow25.4%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$3.46Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic$3.47Net income per basic share, as reported (split-adjusted).
Revenue per share$51.87Revenue / diluted weighted shares.
FCF per share$2.72Free cash flow / diluted weighted shares.
Operating cash flow per share$3.64Cash from operations / diluted weighted shares.
Book value per share$15.08Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$13.67Tangible book value / shares outstanding.
Cash per share$8.82(Cash + short-term investments) / shares outstanding.
Dividend per share$0.26Dividend declared per common share (paid, when declared is not tagged).
Payout ratio7.5%Dividends paid / net income, when net income is positive.
Dividends / FCF9.6%Dividends paid / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$2.07BShare price x shares outstanding.
Enterprise value$1.85BMarket cap + total debt - cash - short-term investments.
P/E23.9xMarket cap / net income. Only when net income is positive.
P/S1.59xMarket cap / revenue.
P/B5.48xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book6.05xMarket cap / tangible book value, when positive.
P/FCF30.5xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF22.7xMarket cap / cash from operations, when positive.
EV/Sales1.42xEnterprise value / revenue.
EV/EBIT15.3xEnterprise value / operating income, when both are positive.
EV/EBITDA13.0xEnterprise value / EBITDA, when both are positive.
EV/FCF27.2xEnterprise value / free cash flow, when both are positive.
FCF yield3.3%Free cash flow / market cap.
Earnings yield4.2%Net income / market cap (the inverse of P/E).
Dividend yield0.3%Dividends paid over the period / market cap.
Shareholder yield0.3%(Dividends paid + share buybacks) / market cap.
PEG0.80xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was IDT CORP's revenue in fiscal 2026?

IDT CORP reported revenue of $1.30B for fiscal 2026, 5.4% higher than the year before.

Was IDT CORP profitable in fiscal 2026?

Yes. Net income was $86.6M, a net margin of 6.7%.

How much free cash flow did IDT CORP generate in fiscal 2026?

Cash from operations of $91.1M minus capital expenditures of $23.1M left free cash flow of $68.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to IDT CORP